Please use this identifier to cite or link to this item:
https://doi.org/10.1186/1471-2458-11-S2-S6
Title: | Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic | Authors: | Burke, R.L Vest, K.G Eick, A.A |
Keywords: | government health human influenza Influenza virus A H1N1 military medicine pandemic respiratory tract disease review sentinel surveillance United States Humans Influenza A Virus, H1N1 Subtype Influenza, Human Military Medicine Pandemics Respiratory Tract Diseases Sentinel Surveillance United States United States Department of Defense World Health |
Issue Date: | 2011 | Citation: | Burke, R.L, Vest, K.G, Eick, A.A (2011). Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic. BMC Public Health 11 (SUPPL. 2) : S6. ScholarBank@NUS Repository. https://doi.org/10.1186/1471-2458-11-S2-S6 | Rights: | Attribution 4.0 International | Abstract: | The Armed Forces Health Surveillance Centers Division of Global Emerging Infections Surveillance and Response System (AFHSC-GEIS) supports and oversees surveillance for emerging infectious diseases, including respiratory diseases, of importance to the U.S. Department of Defense (DoD). AFHSC-GEIS accomplishes this mission by providing funding and oversight to a global network of partners for respiratory disease surveillance. This report details the systems surveillance activities during 2009, with a focus on efforts in responding to the novel H1N1 Influenza A (A/H1N1) pandemic and contributions to global public health. Active surveillance networks established by AFHSC-GEIS partners resulted in the initial detection of novel A/H1N1 influenza in the U.S. and several other countries, and viruses isolated from these activities were used as seed strains for the 2009 pandemic influenza vaccine. Partners also provided diagnostic laboratory training and capacity building to host nations to assist with the novel A/H1N1 pandemic global response, adapted a Food and Drug Administration-approved assay for use on a ruggedized polymerase chain reaction platform for diagnosing novel A/H1N1 in remote settings, and provided estimates of seasonal vaccine effectiveness against novel A/H1N1 illness. Regular reporting of the systems worldwide surveillance findings to the global public health community enabled leaders to make informed decisions on disease mitigation measures and controls for the 2009 A/H1N1 influenza pandemic. AFHSC-GEISs support of a global network contributes to DoDs force health protection, while supporting global public health. © 2011 Burke et al; licensee BioMed Central Ltd. | Source Title: | BMC Public Health | URI: | https://scholarbank.nus.edu.sg/handle/10635/181641 | ISSN: | 14712458 | DOI: | 10.1186/1471-2458-11-S2-S6 | Rights: | Attribution 4.0 International |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1186_1471-2458-11-S2-S6.pdf | 1.11 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License